Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis

Journal of Cellular and Molecular Medicine

Volumn 8, Issue 1, 2004, Pages 109-116

  Campana, F ^a   Zervoudis, Stephane ^a,b,c,d   Perdereau, B ^a   Gez, E ^a   Fourquet, A ^a   Badiu, C ^c   Tsakiris, G ^b   Koulaloglou, S ^b  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF ATHENS   (Greece)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d NONE   (Greece)

Author keywords

Breast irradiation; Free radicals; Radiofibrosis; SOD (Cu Zn); Superoxyde dismutase

Indexed keywords

FREE RADICAL; SCAVENGER; SUPEROXIDE DISMUTASE;

AGED; ARTICLE; BREAST TUMOR; FEMALE; FIBROSIS; HUMAN; INFLAMMATION; MAMMOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; TEMPERATURE; THERMOGRAPHY; TIME;

AGED; BREAST NEOPLASMS; FEMALE; FIBROSIS; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; INFLAMMATION; MAMMOGRAPHY; MIDDLE AGED; SUPEROXIDE DISMUTASE; TEMPERATURE; THERMOGRAPHY; TIME FACTORS;

EID: 3142686722     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2004.tb00265.x     Document Type: Article

References (35)

1. Calle R., Pilleron J.P., Schlienger P., Vilcoq J.R., Conservative management of operable breast cancer: ten years experience at the Foundation Curie, Cancer, 42: 2045-2053, 1978
2. Habibollahi F., Mayles H.M., Mayles W.P., Winter P.J., Tong D., Fentiman I.S., Chaudary M.A., Hayward J.L., Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer, Int. J. Radiat. Oncol. Biol Phys., 14: 291-296, 1988
3. Levit S.H., Perez C.A., Breast cancer. In: Principles and Practice of Radiation Oncology, edited by Perez CA and Brady LW. J.B. Lippincott, 1987, p. 730-792
4. Borger J.H., Kemperman H., Smitt H.S., Hart A., van Dongen J., Lebesque J., Bartelink H., Dose and volume effects on fibrosis after breast conservation therapy, Int. J. Radiat. Oncol. Biol. Phys., 30: 1073-1081, 1994
5. Turesson I., Notter G., The influence of fraction size in radiotherapy on the late normal tissue reaction-I: Comparison of the effects of daily and once-a-week fractionation on human skin, Int. J. Radiat. Oncol. Biol. Phys., 10: 593-598, 1984
6. Van Limbergen E., Rijnders A., van der S.E., Lerut T., Christiaens R., Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results, Radiother. Oncol., 16: 253-267, 1989
7. Fleck R., McNeese M.D., Ellerbroek N.A., Hunter T.A., Holmes F.A., Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int. J. Radiat. Oncol. Biol. Phys., 17: 829-833, 1989
8. Wazer D.E., DiPetrillo T., Schmidt-Ullrich R., Weld L., Smith T.J., Marchant D.J., Robert N.J., Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma, J. Clin. Oncol., 10: 356-363, 1992
9. Beadle G.F., Come S., Henderson I.C., Silver B., Hellman S., Harris J.R., The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys., 10: 2131-2137, 1984
10. Turesson I., Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys., 19: 1569-1574, 1990
11. Del Maestro R., Thaw H.H., Bjork J., Planker M., Arfors K.E., Free radicals as mediators of tissue injury, Acta Physiol. Scand. Suppl., 492: 43-57, 1980
12. Michelson A.M., Toxicity of superoxide radical anions. In: Superoxide and Superoxide Dismutase, edited by Michelson AM, McCord I.M. and Fridovich. Academic Press, 1977, p. 245-256
13. Niwa Y., Oxidative injury and its defense system in vivo, Rinsho Byori, 47: 189-209, 1999
14. Klug D., Rabani J., Fridovich I., A direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis, J. Biol. Chem., 247: 4839-4842, 1972
15. Tainer J.A., Getzoff E.D., Richardson J.S., Richardson D.C., Structure and mechanism of copper, zinc superoxide dismutase, Nature, 306: 284-287, 1983
16. Monte M., Sacerdote d.L., Free radicals of oxygen and superoxide dismutase. Biological and medical aspects, Medicina (B. Aires), 54: 61-68, 1994
17. Petkau A., Scientific basis for the clinical use of superoxide dismutase. Cancer Treat. Rev., 13: 17-44, 1986
18. Lorette G., Machet L., Radiation-induced skin toxicities: prevention, treatment, Cancer Radiother., 5 Suppl 1: 116s-120s, 2001
19. Jones J.B., Cramer H.M., Inch W.R., Lampe H.B., Radioprotective effect of free radical scavenging enzymes. J. Otolaryngol., 19: 299-306, 1990
20. Overgaard J., Nielsen O.S., Overgaard M., Steenholdt S., Jakobsen A., Sell A., Lack of radiation protective effect of orgotein in normal and malignant mammalian cells. Acta Radiol. Oncol. Radiat. Phys. Biol., 18: 305-312, 1979
21. Petkau A., Chelack W.S., Radioprotection by superoxide dismutase of macrophage progenitor cells from mouse bone marrow. Biochem. Biophys. Res. Commun., 119: 1089-1095, 1984
22. Frick J., Banner C., Kunit G., Clinical experiences with orgotein in urologic diseases, Eur. J. Rheumatol. Inflamm., 4: 260-263, 1981
23. Housset M., Baillet F., Michelson A.M., Puget K. Action of liposomal superoxide dismutase on measurable radiation-induced fibrosis, Ann. Med. Interne (Paris), 140: 365-367, 1989
24. Delanian S., Baillet F., Huart J., Lefaix J.L., Maulard C., Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial, Radiother. Oncol., 32: 12-20, 1994
25. Benyahia B., Campana F., Perdereau B., Gez A., Fourquet A., Magdelenat H. The effects of superoxide dismutase topical treatment on human skin radiofibrosis: a pathological study, The Breast, 5: 75-81, 1996
26. Seth L.R., Kharb S., Kharb D.P., Serum biochemical markers in carcinoma breast. Indian J. Med. Sci., 57: 350-354, 2003
27. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashok S., Husain S.A., Lipid peroxidation, free radical production and antioxidant status in breast cancer, Breast Cancer Res. Treat., 59: 163-170, 2000
28. Knight J.A., Onay U.V., Wells S., Li H., Shi E.J., Andrulis I.L., Ozcelik H., Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry, Cancer Epidemiol. Biomarkers Prev., 13: 146-149, 2004
29. Duan H., Zhang H.J., Yang J.Q., Oberley L.W., Futscher B.W., Domann F.E., MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells, Antioxid. Redox. Signal., 5: 677-688, 2003
30. Huber W., Orgotein-(bovine Cu-Zn superoxide dismutase), an anti-inflammatory protein drug: discovery, toxicology and pharmacology. Eur. J. Rheumatol. Inflamm., 4: 173-182, 1981
31. Carson S., Vogin E.E., Huber W., Schulte T.L., Safety tests of orgotein, an antiinflammatory protein, Toxicol. Appl. Pharmacol., 26: 184-202, 1973
32. Nielsen O.S., Overgaard J., Overgaard M., Steenholdt S., Jakobsen A., Sell A., Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect, Acta Oncol., 26: 101-104, 1987
33. Delanian S., Martin M., Bravard A., Luccioni C., Lefaix J.L., Abnormal phenotype of cultured fibroblasts in human skin with chronic radiotherapy damage. Radiother. Oncol., 47: 255-261, 1998
34. Somack R., Saifer M.G., Williams L.D., Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000-72,000 daltons), Free Radic. Res. Commun., 12-13 Pt 2: 553-562, 1991
35. Mehvar R., Modulation of the Pharmacokinetics and Pharmacodynamics of Proteins by Polyethylene Glycol Conjugation, J. Pharm. Pharmaceut. Sci., 3: 125-136, 2000